We are live on ! Find out more
AIM

AIM ImmunoTech
AIM

13 hedge funds and large institutions have $1.01M invested in AIM ImmunoTech in 2018 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

86% more capital invested

Capital invested by funds: $544K → $1.01M (+$467K)

33% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 3

8% more funds holding

Funds holding: 12 → 13 (+1)

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

Holders
13
Holders Change
+1
Holders Change %
+8.33%
% of All Funds
0.3%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
1
Reduced
2
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
+$645K
2
UBS Group
UBS Group
Switzerland
+$7.32K
3
Invesco
Invesco
Georgia
+$4.39K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$4.39K
5
HNB
Huntington National Bank
Ohio
+$1.46K

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$48.3K
2
TSS
Two Sigma Securities
New York
-$11K
3
GC
Guggenheim Capital
Illinois
-$8K
4
Bank of New York Mellon
Bank of New York Mellon
New York
-$4K
5
VF
Virtu Financial
New York
-$1.46K
Name Holding Trade Value Shares
Change 		Change in
Stake
SM
1
Sabby Management
Florida
$620K +$645K +441 New
Vanguard Group
2
Vanguard Group
Pennsylvania
$150K +$4.39K +3 +3%
BlackRock
3
BlackRock
New York
$146K – – –
Geode Capital Management
4
Geode Capital Management
Massachusetts
$23K – – –
Citadel Advisors
5
Citadel Advisors
Florida
$18K -$48.3K -33 -72%
Creative Planning
6
Creative Planning
Kansas
$13K – – –
Northern Trust
7
Northern Trust
Illinois
$11K – – –
VF
8
Virtu Financial
New York
$10K -$1.46K -1 -13%
UBS Group
9
UBS Group
Switzerland
$7K +$7.32K +5 New
OAM
10
Occidental Asset Management
California
$5K – – –
Invesco
11
Invesco
Georgia
$4K +$4.39K +3 New
WPW
12
Waldron Private Wealth
Pennsylvania
$3K – – –
Royal Bank of Canada
13
Royal Bank of Canada
Ontario, Canada
$1K – – –
TSS
14
Two Sigma Securities
New York
– -$11K -7 Closed
GC
15
Guggenheim Capital
Illinois
– -$8K -4 Closed
Bank of New York Mellon
16
Bank of New York Mellon
New York
– -$4K -2 Closed
HNB
17
Huntington National Bank
Ohio
– +$1.46K +1 New

AIM Hedge Fund Activity: Q2 2018 in Review

13 of the 4,369 institutional investors tracked by Wall St. Rank reported a position in AIM ImmunoTech (AIM) for Q2 2018, worth a combined $1.01M — up 86% from $544K a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new AIM positions and 3 closed out — a net gain of 1 holder — while 1 added to existing stakes and 2 trimmed.

The largest buyer was Sabby Management, opening a new position worth an estimated $645K. The largest seller was Citadel Advisors, cutting an estimated $48.3K.

  • 13 institutional investors held AIM ImmunoTech (AIM) as of Q2 2018, up from 12 in Q1 2018.
  • Funds reported $1.01M of AIM ImmunoTech stock for Q2 2018, up 86% quarter-over-quarter.
  • 4 funds opened new AIM ImmunoTech positions in Q2 2018 and 3 closed out, a net change of +1 holder.
  • The largest AIM ImmunoTech buyer in Q2 2018 was Sabby Management, an estimated $645K added.
  • The largest AIM ImmunoTech seller in Q2 2018 was Citadel Advisors, an estimated $48.3K sold.

Based on aggregated 13F filings for Q2 2018.